Mentions
Extended reach
Total likes
Video views
AI synopsis
The collective discussions demonstrate high engagement through references to the study's key findings, such as the noninferiority of early surgery, and utilize confident language like 'noninferior' and 'shorter hospital stays,' which showcases the relevance and potential impact on patient care. Questions about timing indicate ongoing curiosity and assessment of clinical practices surrounding the findings.
Most discussions support the findings, emphasizing that early surgery is as safe as delayed procedures, reflecting general agreement with the study’s conclusions.
Participants display high curiosity, as evidenced by questions like 'How soon is too soon for surgery?' and references to the study in prominent outlets, indicating strong interest in clinical implications.
Posts reference specific details such as noninferiority and perioperative bleeding rates, showing a meaningful level of analysis and engagement with the research data.
The discussions highlight the potential influence on surgical timing decisions, with phrases like 'early surgery is noninferior' and mentions of shortened hospital stays, indicating a moderate but meaningful impact on clinical practice.
Early bypass surgery at 2-3 days is noninferior to surgery at 5-7 days for perioperative bleeding in patients with ACS treated with ticagrelor. @DerekSoMD @HeartInstitute @ICMtl https://t.co/Hjp64uZKM1
Early bypass surgery at 2-3 days is noninferior to surgery at 5-7 days for perioperative bleeding in patients with ACS treated with ticagrelor. https://t.co/ISVyrHfao0 @DerekSoMD @HeartInstitute @ICMtl https://t.co/pESzsQYnmG
Early vs Delayed CABG Surgery for Acute Coronary Syndrome After Ticagrelor https://t.co/G8AtOi4wXa
Read a summary of "Early vs delayed bypass surgery in patients with acute coronary syndrome receiving ticagrelor: The RAPID CABG randomized open-label noninferiority trial," in the June 2025 Science, Medicine, and the Anesthesiologist: https://t.co/WMh7WcJg1z https://t.co/vJR51b4O5B
Early vs Delayed CABGin Patients With Acute Coronary Syndrome Receiving Ticagrelor: The RAPID CABG Randomized Open-Label Noninferiority Trial JAMA Surgery | @JAMA_current https://t.co/yM6p4kXeC5
How soon is too soon for surgery after starting ticagrelor?
This video discusses whether early CABG (2-3 days after stopping ticagrelor) is as safe as delaying (5-7 days), focusing on perioperative bleeding risks and implications for clinical practice, based on recent research…
How soon is too soon for surgery after starting ticagrelor?
RT @_Anesthesiology: Read a summary of "Early vs delayed bypass surgery in patients with acute coronary syndrome receiving ticagrelor: The…
Read a summary of "Early vs delayed bypass surgery in patients with acute coronary syndrome receiving ticagrelor: The RAPID CABG randomized open-label noninferiority trial," in the June 2025 Science, Medicine, and the Anesthesiologist: https://t.co/WMh7WcJg1z https://t.co/vJR51b4O5B
RT @JAMASurgery: Early bypass surgery at 2-3 days is noninferior to surgery at 5-7 days for perioperative bleeding in patients with ACS tre…
Early bypass surgery at 2-3 days is noninferior to surgery at 5-7 days for perioperative bleeding in patients with ACS treated with ticagrelor. @DerekSoMD @HeartInstitute @ICMtl https://t.co/Hjp64uZKM1
RT @Coronary4front: Early vs Delayed CABG Surgery for Acute Coronary Syndrome After Ticagrelor https://t.co/G8AtOi4wXa
RT @Coronary4front: Early vs Delayed CABG Surgery for Acute Coronary Syndrome After Ticagrelor https://t.co/G8AtOi4wXa
RT @Coronary4front: Early vs Delayed CABG Surgery for Acute Coronary Syndrome After Ticagrelor https://t.co/G8AtOi4wXa
Early vs Delayed CABG Surgery for Acute Coronary Syndrome After Ticagrelor https://t.co/G8AtOi4wXa
RT @Coronary4front: Early vs Delayed CABGin Patients With Acute Coronary Syndrome Receiving Ticagrelor: The RAPID CABG Randomized Open-Labe…
RT @Coronary4front: Early vs Delayed CABGin Patients With Acute Coronary Syndrome Receiving Ticagrelor: The RAPID CABG Randomized Open-Labe…
RT @JAMASurgery: Early bypass surgery at 2-3 days is noninferior to surgery at 5-7 days for perioperative bleeding in patients with ACS tre…
Early bypass surgery at 2-3 days is noninferior to surgery at 5-7 days for perioperative bleeding in patients with ACS treated with ticagrelor. https://t.co/ISVyrHfao0 @DerekSoMD @HeartInstitute @ICMtl https://t.co/pESzsQYnmG
Early vs Delayed CABGin Patients With Acute Coronary Syndrome Receiving Ticagrelor: The RAPID CABG Randomized Open-Label Noninferiority Trial JAMA Surgery | @JAMA_current https://t.co/yM6p4kXeC5